X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES CADILA HEALTHCARE ALKEM LABORATORIES/
CADILA HEALTHCARE
 
P/E (TTM) x - 34.4 - View Chart
P/BV x 6.1 8.9 69.2% View Chart
Dividend Yield % 0.7 0.7 102.3%  

Financials

 ALKEM LABORATORIES   CADILA HEALTHCARE
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
CADILA HEALTHCARE
Mar-16
ALKEM LABORATORIES/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,589454 349.7%   
Low Rs1,232305 404.6%   
Sales per share (Unadj.) Rs417.596.1 434.4%  
Earnings per share (Unadj.) Rs56.314.9 378.5%  
Cash flow per share (Unadj.) Rs64.717.8 363.0%  
Dividends per share (Unadj.) Rs12.703.20 396.9%  
Dividend yield (eoy) %0.90.8 106.8%  
Book value per share (Unadj.) Rs292.952.3 560.3%  
Shares outstanding (eoy) m119.571,023.74 11.7%   
Bonus/Rights/Conversions -FV5:1-  
Price / Sales ratio x3.43.9 85.6%   
Avg P/E ratio x25.125.5 98.2%  
P/CF ratio (eoy) x21.821.3 102.4%  
Price / Book Value ratio x4.87.3 66.3%  
Dividend payout %22.621.5 104.9%   
Avg Mkt Cap Rs m168,653388,458 43.4%   
No. of employees `000NA15.4 0.0%   
Total wages/salary Rs m9,17113,317 68.9%   
Avg. sales/employee Rs ThNM6,371.1-  
Avg. wages/employee Rs ThNM862.4-  
Avg. net profit/employee Rs ThNM986.1-  
INCOME DATA
Net Sales Rs m49,91598,376 50.7%  
Other income Rs m1,645941 174.8%   
Total revenues Rs m51,56199,317 51.9%   
Gross profit Rs m8,48223,829 35.6%  
Depreciation Rs m1,0063,022 33.3%   
Interest Rs m671486 138.0%   
Profit before tax Rs m8,45121,262 39.7%   
Minority Interest Rs m-114-300 37.9%   
Prior Period Items Rs m05 0.0%   
Extraordinary Inc (Exp) Rs m0-25 0.0%   
Tax Rs m1,6065,716 28.1%   
Profit after tax Rs m6,73115,226 44.2%  
Gross profit margin %17.024.2 70.2%  
Effective tax rate %19.026.9 70.7%   
Net profit margin %13.515.5 87.1%  
BALANCE SHEET DATA
Current assets Rs m27,06244,376 61.0%   
Current liabilities Rs m15,32434,071 45.0%   
Net working cap to sales %23.510.5 224.5%  
Current ratio x1.81.3 135.6%  
Inventory Days Days6754 123.5%  
Debtors Days Days4162 66.2%  
Net fixed assets Rs m12,61047,896 26.3%   
Share capital Rs m2391,024 23.3%   
"Free" reserves Rs m34,49048,746 70.8%   
Net worth Rs m35,02753,519 65.4%   
Long term debt Rs m1,2128,964 13.5%   
Total assets Rs m54,387100,163 54.3%  
Interest coverage x13.644.7 30.4%   
Debt to equity ratio x00.2 20.7%  
Sales to assets ratio x0.91.0 93.4%   
Return on assets %13.615.7 86.8%  
Return on equity %19.228.4 67.5%  
Return on capital %24.934.3 72.5%  
Exports to sales %12.945.3 28.6%   
Imports to sales %3.15.9 52.0%   
Exports (fob) Rs m6,46144,537 14.5%   
Imports (cif) Rs m1,5405,838 26.4%   
Fx inflow Rs m6,56344,881 14.6%   
Fx outflow Rs m3,0129,069 33.2%   
Net fx Rs m3,55235,812 9.9%   
CASH FLOW
From Operations Rs m7,25919,938 36.4%  
From Investments Rs m1,864-9,039 -20.6%  
From Financial Activity Rs m-9,273-9,527 97.3%  
Net Cashflow Rs m-1501,372 -10.9%  

Share Holding

Indian Promoters % 66.9 74.8 89.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 8.3 398.8%  
FIIs % 0.0 5.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 11.0 -  
Shareholders   68,381 44,069 155.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Strong; Consumer Durables Stocks Drag(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are trading above the dotted line. Except stocks in the consumer durables sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 23, 2017 01:45 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - NATCO PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS